---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-057617"
form_type: "8-K/A"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2026-08-18T18:03:52+00:00"
generated_at: "2026-08-18T18:05:06.038701+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Iradimed Q2 revenue flat at $20.5M, EPS down 9% to $0.41; reaffirms FY guidance

## Summary
- Q2 revenue $20.5M, up 0.5% YoY; GAAP EPS $0.41, down 9%; non-GAAP EPS $0.46, down 7%.
- Net income $5.2M, down 10% YoY; gross margin 74% vs 78% prior year.
- Declares $0.20/share quarterly dividend, payable Aug 28, 2026, record Aug 14, 2026.
- Reaffirms FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP $2.09-2.24.
- New 3870 MR IV pump launch underway; >70% of new pump orders for quad stack configuration.

## SEC filing metadata
- accession: 0001628280-26-057617
- form_type: 8-K/A
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2026-08-18T18:03:52+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/0001628280-26-057617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/irmd-20260731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-057617
- JSON: https://secwatch.observer/filing/0001628280-26-057617.json
- Plain text: https://secwatch.observer/filing/0001628280-26-057617.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.